📖

CTAD 2026: Amyloid-Targeting Antibody Trial Results

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-events-ctad-2026-amyloid-antibody-t
Related Entities
events-ctad-2026-amyloid-antibody-trials
Metadata
slugevents-ctad-2026-amyloid-antibody-trials
entity_typeevent
kg_node_idNone
Linked Artifacts (79)
related🧫Cytochrome Therapeutics70%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap70%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#70%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&70%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag70%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'70%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#70%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin70%
related🧫Protein Aggregation Kinetic Validation Results70%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson70%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise70%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di70%
related🧫Experiment Validation: In vitro ThT Assay70%
related🧫Cytochrome Therapeutics70%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap70%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#70%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&70%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag70%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'70%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#70%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin70%
related🧫Protein Aggregation Kinetic Validation Results70%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson70%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise70%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di70%
related🧫Experiment Validation: In vitro ThT Assay70%
mentions🧪APOE Isoform Conversion Therapy50%
mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%
mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%
mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%
mentions🧪APOE4-Selective Lipid Nanoemulsion Therapy50%
mentions🧪Competitive APOE4 Domain Stabilization Peptides50%
mentions🧪APOE Isoform Expression Across Glial Subtypes50%
mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation50%
mentions🧪TREM2-Dependent Microglial Senescence Transition50%
mentions🧪TREM2-mediated microglial tau clearance enhancement50%
mentions🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia50%
mentions🧪Glymphatic System-Enhanced Antibody Clearance Reversal50%
mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%
mentions🧪DNMT1-Targeting Antisense Oligonucleotide Reset50%
mentions🧪Metabolic Switch Targeting for A1→A2 Repolarization50%
mentions🧪Phase-Separated Organelle Targeting50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬What are the most promising therapeutic strategies for targe50%
related🔬TDP-43 undergoes liquid-liquid phase separation that becomes50%
related🔬Anti-amyloid antibodies (lecanemab, donanemab) have ~0.1% br50%
related🔬APOE4 differs from APOE3 by C112R causing domain interaction50%
related🔬Senolytics targeting p16/p21+ senescent astrocytes and micro50%
related🧪TREM2 Conformational Stabilizers for Synaptic Discrimination50%
related🧪APOE-TREM2 Interaction Modulation50%
related🧪TREM2-Mediated Selective Aggregate Clearance Pathway50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
mentions🔬Investigate how lipid raft composition (cholesterol metaboli40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬Anti-amyloid antibodies (lecanemab, donanemab) have ~0.1% br40%
mentions🔬APOE4 differs from APOE3 by C112R causing domain interaction40%
mentions🔬What are the mechanisms underlying blood-brain barrier trans40%
mentions🔬What are the mechanisms underlying apoe4 structural biology 40%
mentions🔬What are the most promising therapeutic strategies for targe40%
mentions🔬TDP-43 undergoes liquid-liquid phase separation that becomes40%
mentions🔬Senolytics targeting p16/p21+ senescent astrocytes and micro40%
related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer40%
related🧪Glymphatic System-Enhanced Antibody Clearance Reversal40%
related🧪DNMT1-Targeting Antisense Oligonucleotide Reset40%
related🧪Metabolic Switch Targeting for A1→A2 Repolarization40%
related🧪Phase-Separated Organelle Targeting40%